Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CytoDyn Inc
CYDY
Healthcare
Biotechnology
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including...
infectious disease, cancer, and autoimmune conditions. Its core areas of clinical development are human immunodeficiency viruses (HIV), non-alcoholic steatohepatitis (NASH), and solid tumors in oncology. The areas of clinical focus in HIV are the lifting of the clinical hold, creation of a long-acting formulation of leronlimab and an HIV functional cure in using adenovirus vectors (AAV). In NASH, its focus is on the general population of those affected by NASH, and the subpopulation of patients with NASH and HIV. Regarding oncology, its focus remains on combination therapy for solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CYDY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on Apr 19, 2020 8:04am
Cydy on Fox News:
[url]https://youtu.be/8YaOr7ggyTw[/url]
(0)
•••
Theacer
X
View Profile
View Bullboard History
Comment by
Theacer
on Apr 02, 2020 1:33pm
RE:RE:RE:Fleeced?
I just wonder if it's the miracle "Covid-19" winner or if that was more a pump. I was able to grab some at $2;25 so trade this if it pops. GLTA
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Apr 02, 2020 1:25pm
RE:RE:Fleeced?
This is still a good one to trade.
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Apr 02, 2020 1:20pm
RE:Fleeced?
I sold at 3.10 Made almost a full point. It dropped off so quick after it hit a new high. Going to stick with gold stocks for now.
(0)
•••
Theacer
X
View Profile
View Bullboard History
Post by
Theacer
on Apr 02, 2020 1:03pm
Fleeced?
I would say this was all hype - big drop today!
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Apr 02, 2020 9:15am
RE:RE:Vancouver company has possible treatment for coronavirus
Yes, I was going to correct that but Considering the ticker symbol people can figure it out. More great News today. Opening @ $3.30 No one here. lol
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Apr 01, 2020 3:17pm
RE:Vancouver company has possible treatment for coronavirus
Vancouver, Washington that is. Probably better to say it that way on a Stockhouse board.
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Mar 31, 2020 10:54am
CYDY
Hope people bought this morning below $3.00 This is going to $6.00 Read the news!
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Mar 31, 2020 6:13am
NEWS! FDA Clears CytoDyn’s Phase 2
March 31, 2020FDA Clears CytoDyn’s Phase 2Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients withLeronlimab; Enrollment to BeginImmediatelyVANCOUVER, Washington, March 31, 2020
...more
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Mar 30, 2020 9:56pm
Vancouver company has possible treatment for coronavirus
Vancouver company has possible treatment for coronavirus https://katu.com/news/coronavirus/vancouver-company-has-possible-treatment-for-coronavirus
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Mar 30, 2020 9:17pm
RE:CYDY mentioned on FOX news tonight. 54:00
It's near the beginning about 5:00 in? scroll when you see the "BEATING THE CHINESE CORONAVIRUS" with DR. Marc Segal Lieronimab was just mentioned on Tucker Carlson interview with
...more
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Post by
LowMoor
on Mar 30, 2020 9:05pm
CYDY mentioned on FOX news tonight. 54:00
(56)
•••
LowMoor
X
View Profile
View Bullboard History
Comment by
LowMoor
on Mar 30, 2020 7:57pm
RE:Pro 140 is a miracle!
WOW! Nice news today. I quickly but a few shares. This can still double or more from this price. Cheers!
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market